PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY (STRATEGE) SHOWS THE EFFICACY OF TREAT-TO-TARGET STRATEGY AND METHOTREXATE MONOTHERAPY OPTIMIZATION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS

被引：0
|
作者：
Flipo, R. -M. [1 ]
Gaujoux-Viala, C. [2 ,3 ]
Hudry, C. [4 ,5 ]
Zinovieva, E. [6 ]
Herman-Demars, H. [6 ]
机构：
[1] Lille Univ Hosp Roger Salengro, Dept Rheumatol, Lille, France
[2] Nimes Hosp, Dept Rheumatol, Nimes, France
[3] Montpellier Univ, Montpellier, France
[4] Cochin Hosp, Rheumatol Inst, Paris, France
[5] Cochin Hosp, Rheumatol Dept, Paris, France
[6] Nord Pharma, Med Dept, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.2707
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0057
引用
收藏
页码：789 / 789
页数：1
相关论文
共 50 条
  • [21] ADHERENCE TO TREAT-TO-TARGET APPROACH IN A RHEUMATOID ARTHRITIS COHORT: RETROSPECTIVE ANALYSIS FROM 3 YEARS OF REAL-LIFE EXPERIENCE IN A REFRACTORY CLINIC
    Maranini, B.
    Silvagni, E.
    Venturelli, V.
    Piovani, A.
    Zagnoni, E.
    Govoni, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1295 - 1296
  • [22] Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study
    Guidelli, G. M.
    Viapiana, O.
    Luciano, N.
    De Santis, M.
    Boffini, N.
    Quartuccio, L.
    Birra, D.
    Conticini, E.
    Chimenti, M. S.
    Bazzani, C.
    Bruschi, E.
    Riva, M.
    Canziani, L. M.
    Bianchi, G.
    Pozzi, M. R.
    Limonta, M.
    Gorla, R.
    Perricone, R.
    Frediani, B.
    Moscato, P.
    De Vita, S.
    Dagna, L.
    Rossini, M.
    Selmi, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : 868 - 873
  • [23] REAL-LIFE IMPLEMENTATION OF A LDL-C TREAT-TO-TARGET STRATEGY IN THE MANAGEMENT OF HYPERLIPIDEMIA IN HIGH CVD RISK PATIENTS IN QUEBEC
    Kouz, S.
    Constance, C.
    Rampakakis, E.
    Psaradellis, E.
    Sampalis, J.
    De Carolis, E.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S244 - S245
  • [24] Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study
    Baldi, Caterina
    Parisi, Simone
    Falsetti, Paolo
    Sota, Jurgen
    Ditto, Maria Chiara
    Capassoni, Marco
    D'alessandro, Miriana
    Conticini, Edoardo
    Nacci, Francesca
    Peroni, Clara Lisa
    Cometi, Laura
    Fusaro, Enrico
    Frediani, Bruno
    Guiducci, Serena
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [25] SIMILAR EFFICACY AND DRUG SURVIVAL RATES OF BARICITINIB MONOTHERAPY AND BARICITINIB/METHOTREXATE COMBINATION THERAPY IN REAL-LIFE TREATMENT OF RHEUMATOID ARTHRITIS - RESULTS FROM A PROSPECTIVE COHORT OF BARICITINIB-TREATED PATIENTS
    Bayat, S.
    Tascilar, K.
    Bohr, D.
    Simon, D.
    Kronke, G.
    Hartmann, F.
    Knitza, J.
    Schett, G.
    Kleyer, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 629 - 629
  • [26] VALIDITY OF TREAT TO TARGET STRATEGY FOR COMPREHENSIVE DISEASE CONTROL IN CHINESE PATIENTS WITH RHEUMATOID ARTHRITIS: A REAL-WORLD, PROSPECTIVE COHORT STUDY
    Ma, J.
    Wang, X.
    Mo, Y.
    Chen, L.
    Dai, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 972 - 972
  • [27] The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational "real-life" study
    Di Muzio, Claudia
    Conforti, Alessandro
    Bruno, Federico
    Currado, Damiano
    Berardicurti, Onorina
    Navarini, Luca
    Pavlych, Viktoriya
    Di Cola, Ilenia
    Biaggi, Alice
    Di Donato, Stefano
    Marino, Annalisa
    Lorusso, Sebastiano
    Ursini, Francesco
    Barile, Antonio
    Masciocchi, Carlo
    Cipriani, Paola
    Giacomelli, Roberto
    Ruscitti, Piero
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [28] The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study
    Claudia Di Muzio
    Alessandro Conforti
    Federico Bruno
    Damiano Currado
    Onorina Berardicurti
    Luca Navarini
    Viktoriya Pavlych
    Ilenia Di Cola
    Alice Biaggi
    Stefano Di Donato
    Annalisa Marino
    Sebastiano Lorusso
    Francesco Ursini
    Antonio Barile
    Carlo Masciocchi
    Paola Cipriani
    Roberto Giacomelli
    Piero Ruscitti
    Scientific Reports, 13
  • [29] Long-term outcome of a treat-to-target strategy in late-onset rheumatoid arthritis with chronic lung disease: 5-year results of a prospective observational study
    Nomura, Manami
    Sugihara, Takahiko
    Baba, Hiroyuki
    Hosoya, Tadashi
    Kamiya, Mari
    Ishizaki, Tatsuro
    Matsumoto, Takumi
    Kubo, Kanae
    Hirano, Fumio
    Kojima, Masayo
    Miyasaka, Nobuyuki
    Yasuda, Shinsuke
    Harigai, Masayoshi
    ARTHRITIS RESEARCH & THERAPY, 2025, 27 (01)
  • [30] HIGHER LIKELIHOOD OF RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED IN A REAL-LIFE SETTING WITH ADALIMUMAB IN COMBINATION WITH METHOTREXATE, BUT NOT WITH OTHER DMARDS, VERSUS ADALIMUMAB MONOTHERAPY
    Kiely, Patrick
    Florentinus, Stefan
    Keidel, Sarah
    Karunaratne, Mahinda
    Lacerda, Ana
    RHEUMATOLOGY, 2014, 53 : 98 - 98
12345